Trials / Completed
CompletedNCT03066570
Graded Exposure in Patients With Painful Diabetic Neuropathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objective: To investigate the effects of a cognitive behavioural intervention targeting specific fears in patients with painful diabetic neuropathy, on physical activity and quality of life.
Detailed description
Intervention: Graded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity. Main study parameters/endpoints: The purpose of this project is to develop and test a cognitive behavioural intervention targeting specific fears in patients with PDN, in order to increase physical activity and improve QOL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Graded Exposure | Graded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity. |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2019-03-18
- Completion
- 2019-03-18
- First posted
- 2017-02-28
- Last updated
- 2020-12-03
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03066570. Inclusion in this directory is not an endorsement.